BLS International Q1 FY27 Results: Nuvama Sees 66% Upside, Revenue Rises 25% to ₹891 Crore

BLS International Shares: Nuvama Sees 66% Upside After Strong Q1 FY27 Results

BLS International Services reported a strong start to FY27, with revenue and profitability improving during the June quarter.

Following the results, brokerage firm Nuvama Institutional Equities maintained a Buy rating on the stock with a target price of ₹431 per share, implying potential upside of up to 66% based on the brokerage's assessment.

The company's diversified geographical presence, visa and consular services business, and growing digital operations supported the quarterly performance.

Q1 FY27 Financial Highlights

BLS International delivered healthy growth during the April-June 2026 quarter.

Revenue: ₹891 Crore (+25.3% YoY)

PAT: ₹201.6 Crore (+11.4% YoY)

EBITDA: ₹252 Crore (+23.6% YoY)

The company reported revenue of ₹891 crore compared with the year-ago period, while profit after tax increased from ₹181 crore to ₹201.6 crore.

Visa & Consular Services Remain Key Growth Driver

The Visa & Consular Services business continued to be a major contributor to BLS International's performance.

Revenue from the segment increased 21.6% YoY, while EBITDA grew 21.5% YoY.

According to Nuvama, margins in the visa and consular services business remained around 40%, supported by higher realisations and a favourable contract mix despite stable application volumes.

Recent visa wins and a healthy tender pipeline are expected to provide additional growth visibility.

Digital Services Continue to Expand

BLS International's Digital Services business also delivered strong growth.

Revenue Growth: 32.2% YoY

EBITDA Growth: 45% YoY

The company attributed the performance to continued investments in technology platforms, talent and digital capabilities.

Nuvama noted that the digital business is expanding, although its margins remain structurally lower than the visa and consular services business.

Nuvama's ₹431 Target Price

Nuvama Institutional Equities has maintained its Buy rating on BLS International with a target price of:

₹431 per share

The brokerage highlighted several factors supporting its outlook

• Healthy start to FY27
• Strong visa and consular services margins
• Recent visa contract wins
• Healthy tender pipeline
• Expansion in digital services
• Management's 15–20% organic growth target
• Additional growth opportunities from Atyati Technologies and the Aadhaar project

Nuvama also noted that execution and the pace of contribution from these new opportunities will remain important monitorables.

BLS International Share Price Trend

BLS International shares have remained volatile amid weak market sentiment.

The stock has

• Gained 2.64% in one week
• Gained 10.68% in one month
• Declined 6.31% over six months
• Declined 17.11% on a YTD basis
• Delivered around 589% returns over five years

The recent monthly recovery comes as investors assess the company's Q1 performance and future growth opportunities.

Key Growth Drivers

Several factors could remain important for BLS International's growth

• Strong visa and consular services business
• Higher operating leverage
• Recent visa wins
• Healthy tender pipeline
• Expansion of digital services
• 15–20% organic growth target
• Atyati Technologies opportunity
• Aadhaar project opportunity
• Diversified global presence

Key Takeaways

• BLS International reported ₹891 crore revenue in Q1 FY27.
• Revenue increased 25.3% YoY.
• PAT rose 11.4% YoY to ₹201.6 crore.
• EBITDA increased 23.6% YoY to ₹252 crore.
• Digital Services revenue grew 32.2% YoY.
• Nuvama retained its Buy rating.
• Nuvama's target price stands at ₹431.
• The brokerage sees potential upside of around 66%.
• Visa wins, tender pipeline and new business initiatives remain key factors to monitor.

Disclaimer

This article is published solely for educational and informational purposes and should not be considered financial, investment, legal, or tax advice. The information presented is based on publicly available sources and is believed to be accurate at the time of publication; however, TrendRipperX does not guarantee its completeness or accuracy.

TrendRipperX is not registered with the Securities and Exchange Board of India (SEBI) as an Investment Adviser or Research Analyst. Any views expressed are for informational purposes only and do not constitute a recommendation to buy, sell, or hold any security.

The ₹431 target price and Buy rating are those of Nuvama Institutional Equities, as reported in the source material, and are not a recommendation from TrendRipperX.

Investments in financial markets are subject to market risks. Readers should conduct their own research and consult a SEBI-registered financial advisor before making any investment decisions.